Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Bruce D. Cheson, John M. Bennett, Thomas Büchner et al. · Journal of Clinical Oncology · 2003 · 2.7K citations

Medicine, Hematology, Oncology +17

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 449 citations · Full text

Medicine, Hematology, Oncology +16

Acute Myeloid Leukemia

Margaret R. O'Donnell, Camille N. Abboud, Jessica K. Altman et al. · Journal of the National Comprehensive Cancer Network · 2012 · 326 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact on Outcome in Acute Myeloid Leukemia

Xueyan Chen, Hu Xie, Brent L. Wood et al. · Journal of Clinical Oncology · 2015 · 258 citations · Full text

Medicine, Hematology, Oncology +17

Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia

Hiroto Inaba, Elaine Coustan‐Smith, Xueyuan Cao et al. · Journal of Clinical Oncology · 2012 · 213 citations · Full text

Medicine, Hematology, Oncology +16